Comparison between liposomal formulations of amphotericin B.

Comparison between liposomal formulations of amphotericin B.

Item
http://www.wikidata.org/entity/Q38696930
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry.Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis.Comparison of the pharmacokinetic profiles of two different amphotericin B formulations in healthy dogs.Tissue pharmacokinetics and pharmacodynamics of AmBisome® (L-AmBis) in uninfected and infected animals and their effects on dosing regimens.The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles.Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis.Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis
P2860

Comparison between liposomal formulations of amphotericin B.

Item
http://www.wikidata.org/entity/Q38696930
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Comparison between liposomal formulations of amphotericin B.
@en
type
label
Comparison between liposomal formulations of amphotericin B.
@en
prefLabel
Comparison between liposomal formulations of amphotericin B.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Comparison between liposomal formulations of amphotericin B.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698